ArticleInternational journal of hematology2017

A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece.

Vasiliki Pappa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.